Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Overactivity”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Not applicableUnknownNCT04693897
What this trial is testing

Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker

Who this might be right for
Overactive Bladder SyndromeDetrusor Overactivity
Chang Gung Memorial Hospital 400
Not applicableUnknownNCT04578899
What this trial is testing

"The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity"

Who this might be right for
Overactive Bladder
Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation 80
Early research (Phase 1)Study completedNCT01539707
What this trial is testing

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Inc 14
Not applicableLooking for participantsNCT07343583
What this trial is testing

Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury

Who this might be right for
Spinal Cord InjuryDetrusor Overacitivity
Ankara City Hospital Bilkent 45
Not applicableStudy completedNCT04197466
What this trial is testing

Comparison of Different Treatments for Overactive Bladder Syndrome

Who this might be right for
Overactive BladderOveractive Bladder SyndromeOveractive Detrusor
Ankara Yildirim Beyazıt University 66
Post-approval studies (Phase 4)Looking for participantsNCT06479720
What this trial is testing

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Who this might be right for
Effect of DrugUrinary Bladder, Overactive
Mackay Memorial Hospital 300
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Not applicableEnded earlyNCT03080389
What this trial is testing

Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections

Who this might be right for
Overactive BladderOveractive DetrusorUrgency-Frequency Syndrome+1 more
The Cleveland Clinic 16
Not applicableStudy completedNCT01408771
What this trial is testing

"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

Who this might be right for
Overactive Detrusor
Assaf-Harofeh Medical Center 20
Not applicableStudy completedNCT01600404
What this trial is testing

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

Who this might be right for
Mild Cognitive ImpairmentSpinal Cord Injuries
Swiss Paraplegic Research, Nottwil 32
Large-scale testing (Phase 3)Study completedNCT01981954
What this trial is testing

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Who this might be right for
Neurogenic Detrusor OveractivityPediatric
Astellas Pharma Europe B.V. 23
Not applicableEnrolling By InvitationNCT06212661
What this trial is testing

Migraine Medication Effects on Urinary Symptoms

Who this might be right for
Overactive BladderBladder Pain SyndromeMigraine Disorders+4 more
The Cleveland Clinic 200
Not applicableStudy completedNCT06059066
What this trial is testing

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

Who this might be right for
Neurogenic BladderLower Urinary Tract SymptomsOveractive Bladder+2 more
The Methodist Hospital Research Institute 78
Large-scale testing (Phase 3)Study completedNCT01530620
What this trial is testing

Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Urinary Bladder DisorderUrinary Bladder, NeurogenicBladder Disorder, Neurogenic+6 more
APOGEPHA Arzneimittel GmbH 66
Large-scale testing (Phase 3)UnknownNCT01050114
What this trial is testing

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Who this might be right for
Overactive Bladder
Christopher Patrick Smith 36
Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Post-approval studies (Phase 4)Study completedNCT00629642
What this trial is testing

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic BladderSpinal Cord Diseases
Astellas Pharma Inc 249
Post-approval studies (Phase 4)Study completedNCT01093534
What this trial is testing

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

Who this might be right for
Detrusor OveractivityOveractive Bladder
Astellas Pharma Inc 547
Not applicableNot Yet RecruitingNCT07695662
What this trial is testing

The Predictive Value of Lower Extremity Hypertonia on Neurogenic Detrusor Overactivity After Spinal Cord Injury

Who this might be right for
Spinal Cord Injuries (SCI)
Shengjing Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00712322
What this trial is testing

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Warner Chilcott 35
Next Page